Exodus Point Capital Management, LP Moon Lake Immunotherapeutics Transaction History
Exodus Point Capital Management, LP
- $16.4 Billion
- Q3 2024
A detailed history of Exodus Point Capital Management, LP transactions in Moon Lake Immunotherapeutics stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 16,855 shares of MLTX stock, worth $755,272. This represents 0.01% of its overall portfolio holdings.
Number of Shares
16,855Holding current value
$755,272% of portfolio
0.01%Shares
2 transactions
Others Institutions Holding MLTX
# of Institutions
126Shares Held
58.2MCall Options Held
52.2KPut Options Held
38K-
Bvf Inc San Francisco, CA21.8MShares$975 Million34.86% of portfolio
-
Cormorant Asset Management, LP Boston, MA8.49MShares$381 Million30.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.98MShares$134 Million0.02% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.77MShares$124 Million2.1% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.32MShares$104 Million0.02% of portfolio
About MoonLake Immunotherapeutics
- Ticker MLTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,925,600
- Market Cap $1.65B
- Description
- MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or rad...